AmyT

Insulin Shakeout: Lilly, Generics, What’s Next?

When I read the other day that Eli Lilly was halting construction of a new insulin plant in Virginia, I didn’t make that much of it.  Another day, another dollar-based business decision, right?  But it seems there are some strong currents running through the insulin market that will have tangible consequences for us folks who live on insulin, indeed.
Is Eli Lilly really distancing itself from its historical covenant with diabetes?  This is the company…

Read more »

What Gets in the Way

The other bit I wanted to share from my day at the Behavioral Diabetes Institute was our discussion of what gets in the way, i.e. why do many patients so consistently neglect their diabetes?  That is, the first hour of my time at the BDI was spent in a “provider” session sharing concerns with a group of people including CDEs, psychologists, nutritionists, and reps from BDI sponsor Roche Diagnostics.
The topic du jour was what…

Read more »

Fighting For My Life

Time for an update on my campaign to become an insulin pumper.  Ouch. Painful experience dealing with Blue Shield, so far.  Enormous amount of time spent explaining to perfect strangers — from the HR reps at my husband’s company to various “reimbursement managers” to a parade of officials at Blue Shield (forthwith to be referred to as ‘BS’) itself — why I ought to get medical coverage for a life-sustaining device that my doctors have…

Read more »

Nothing Like a Good Group Gripe

This Wednesday evening I had the privilege of speaking at the Behavioral Diabetes Institute in San Diego, alongside its founder Dr. William Polonksy.  Not that we gave formal lectures or anything.  In fact, the session was a great communal discussion of everything that’s exasperating and frightening about living with diabetes — a really good “group gripe” that I’m surprised to say I thoroughly enjoyed.
Isn’t it kind of twisted to feel energized by a room…

Read more »

Showdown Time

Stem cell research and universal health insurance are slamming through the headlines this week, ay? 
First off, the Democrats are “staging a second showdown” over use of embryonic stem cells, pushing for expanded taxpayer-funded research using the controversial cells.  According to the Associated Press, polls show that a majority of Americans support embryonic stem cell research — and Democrats insist that the public demanded action by casting ballots for stem cell supporters in the November…

Read more »